In addition, it is also known that other populations of ‘atypical’ NKT cell subsets (γδ T cells and δ-αβ T cells) can respond to CD1d-α-GalCer (19–21); Yet, the role of these distinct T cell subsets in affecting tumor immunity remains unknown. This evidence concerns the gene CD1D and neoplasm.